Evaluation of Excipient Risk in BCS Class I and III Biowaivers
Crossref DOI link: https://doi.org/10.1208/s12248-021-00670-1
Published Online: 2022-01-05
Published Print: 2022-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Metry, Melissa
Polli, James E.
Text and Data Mining valid from 2022-01-01
Version of Record valid from 2022-01-05
Article History
Received: 7 October 2021
Accepted: 30 November 2021
First Online: 5 January 2022
Declarations
:
: The authors declare no competing interests.